Skip to main content
. 2020 Dec 29;23(3):300–309. doi: 10.1016/j.jmoldx.2020.12.002

Table 2.

Interference Testing at High Concentration of PCDH-Based Pseudovirus

Reagent manufacturer N gene
ORF1ab gene
E gene
Control
2 mg/L DNA
P value Control
2 mg/L DNA
P value Control
2 mg/L DNA
P value
Mean Ct Positive rate Mean Ct Positive rate Mean Ct Positive rate Mean Ct Positive rate Mean Ct Positive rate Mean Ct Positive rate
PerkinElmer 32.07 20/20 31.79 20/20 0.26 31.62 20/20 31.70 20/20 0.39
Wantai 33.33 20/20 33.16 20/20 0.21 33.46 20/20 33.13 20/20 0.06
KHB 28.53 20/20 28.41 20/20 0.03 29.92 20/20 30.02 20/20 0.38 28.52 20/20 28.34 20/20 0.02
Sansure 36.85 20/20 36.65 20/20 0.44 37.45 20/20 37.87 20/20 0.14
Da An 35.58 20/20 35.78 20/20 0.20 37.26 20/20 37.37 20/20 0.46
BioGerm 34.56 20/20 34.46 20/20 0.70 34.89 20/20 34.32 20/20 0.11
ABT 36.02 20/20 36.15 20/20 0.23 36.99 20/20 36.16 20/20 0.01 35.55 20/20 35.55 20/20 0.89

The concentration was 900 copies/mL of N gene, 760 copies/mL of ORF1ab gene, and 670 copies/mL of E gene.

ABT, Beijing Applied Biological Technologies Co, Ltd; BioGerm, Shanghai BioGerm Medical Biotechnology Co, Ltd; Da An, Da An Gene Co, Ltd; KHB, Shanghai Kehua Bio-Engineering Co, Ltd; Sansure, Sansure Biotech Inc.; Wantai, Beijing Wantai Biological Pharmacy Enterprise Co, Ltd.